Interleukin-18 and NGAL in assessment of ESWL treatment safety in children with urolithiasis.
about
Interleukin-18 and NGAL in assessment of ESWL treatment safety in children with urolithiasis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Interleukin-18 and NGAL in ass ...... in children with urolithiasis.
@ast
Interleukin-18 and NGAL in ass ...... in children with urolithiasis.
@en
type
label
Interleukin-18 and NGAL in ass ...... in children with urolithiasis.
@ast
Interleukin-18 and NGAL in ass ...... in children with urolithiasis.
@en
prefLabel
Interleukin-18 and NGAL in ass ...... in children with urolithiasis.
@ast
Interleukin-18 and NGAL in ass ...... in children with urolithiasis.
@en
P2093
P2860
P50
P356
P1476
Interleukin-18 and NGAL in ass ...... in children with urolithiasis.
@en
P2093
Ewa Straż-Żebrowska
Małgorzata Placzyńska
P2860
P304
P356
10.5114/CEJI.2014.45952
P577
2014-10-14T00:00:00Z